BioSpace’s Post

The pharma giant announced Tuesday that Mikael Dolsten is leaving his role as chief science officer after more than 15 years. Pfizer is conducting an external search for a replacement, with Dolsten staying on to assist in the months-long process. https://hubs.li/Q02FRZVF0

The Federal Trade Commission on Tuesday issued an interim report on the top pharmacy benefit managers, showing that they are generating massive profit at the expense of patients by inflating prescription drug costs. https://hubs.li/Q02FRXMG0 #pharma #finance #biospace

Following a disappointing readout last year, uniQure on Tuesday posted promising Phase I/II data for its investigational gene therapy AMT-130 and nabbed the first-ever Regenerative Medicine Advanced Therapy designation from the FDA in Huntington’s disease. https://hubs.li/Q02FRNQ90

House Speaker Mike Johnson (R-La.) on Monday said he intends to have a “significant package of China-related legislation” signed into law by the end of this year, including the #BIOSECURE Act which intends to stop federal contracts with Chinese “companies of concern.” https://hubs.ly/Q02FRvWp0 #pharma #policy #biospace | Office of the Speaker of the United States House of Representatives

Eli Lilly and Company's #Mounjaro outperformed Novo Nordisk's #Ozempic at inducing weight loss in obese or overweight adults, according to an observational study published Monday in JAMA Internal Medicine. https://hubs.li/Q02FPk3x0 #pharma #GLP1 #biospace

Roche's eye implant Susvimo for patients with neovascular age-related macular degeneration is re-entering the U.S. market after the FDA approved updates to the components of the product. https://hubs.li/Q02FPjLd0 #pharma #biospace

The White House Biden administration is appealing a 2023 jury decision that declared invalid its patent protections over Gilead Sciences' HIV prevention regimen of Truvada and Descovy. https://hubs.li/Q02FPj-10 #pharma #legal #biospace

At the DIA Global 2024 Conference, Dr. Peter Marks, Director of the Center for Biological Evaluation and Research (CBER) at the FDA, and Lori Ellis (Katz), Head of Insights at BioSpace, discussed the advancements being made to help drive forward drug and medical device development. Watch the full interview: https://lnkd.in/ga_z9spj #pharma #policy #biospace

The U.K.-based biotech, Myricx Bio, is the latest to cash in on the hot antibody-drug conjugate space, closing a $115.5 million Series A round co-led by Novo Holdings and with participation from Eli Lilly and Company. https://lnkd.in/gJ-VKekY #pharma #seriesA #biospace

GLP-1 receptor agonists could reduce the risk of 10 obesity-associated cancers, such as meningioma, multiple myeloma and colorectal cancer, in type 2 diabetes patients, according to an analysis of electronic health records. https://lnkd.in/gJX7k6W3 #pharma #biospace